Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.1 (
protein kinase
)
81,284
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Phosducin-like protein
(
PhLP
) is a member of the phosducin family of G-protein betagamma-regulators and exists in two splice variants. The long isoform
PhLP
(L) and the short isoform
PhLP
(S) differ by the presence or absence of an 83-amino acid N terminus. In isolated biochemical assay systems,
PhLP
(L) is the more potent Gbetagamma-inhibitor, whereas the functional role of
PhLP
(S) is still unclear. We now report that in intact HEK 293 cells,
PhLP
(S) inhibited Gbetagamma-induced inositol phosphate generation with approximately 20-fold greater potency than
PhLP
(L). Radiolabeling of transfected HEK 293 cells with [(32)P] revealed that
PhLP
(L) is constitutively phosphorylated, whereas
PhLP
(S) is not. Because
PhLP
(L) has several consensus sites for the constitutively active kinase
casein kinase 2
(
CK2
) in its N terminus, we tested the phosphorylation of the recombinant proteins by either HEK cell cytosol in the presence or absence of kinase inhibitors or by purified
CK2
.
PhLP
(L) was a good
CK2
substrate, whereas
PhLP
(S) and phosducin were not. Progressive truncation and serine/threonine to alanine mutations of the
PhLP
(L) N terminus identified a serine/threonine cluster (Ser-18/Thr-19/Ser-20) within a small N-terminal region of
PhLP
(L) (amino acids 5-28) as the site in which
PhLP
(L) function was modified in HEK 293 cells. In native tissue,
PhLP
(L) also seems to be regulated by phosphorylation because phosphorylated and non-phosphorylated forms of
PhLP
(L) were detected in mouse brain and adrenal gland. Moreover, the alternatively spliced isoform
PhLP
(S) was also found in adrenal tissue. Therefore, the physiological control of G-protein regulation by
PhLP
seems to involve phosphorylation by
CK2
and alternative splicing of the regulator.
...
PMID:Regulation of phosducin-like protein by casein kinase 2 and N-terminal splicing. 1246 82
Phosducin-like protein
(
PhLP
) is a widely expressed binding partner of the G protein betagamma subunit dimer (Gbetagamma). However, its physiological role is poorly understood. To investigate
PhLP
function, its cellular expression was blocked using RNA interference, resulting in inhibition of Gbetagamma expression and G protein signaling. This inhibition was caused by an inability of nascent Gbetagamma to form dimers. Phosphorylation of
PhLP
at serines 18-20 by
protein kinase CK2
was required for Gbetagamma formation, while a high-affinity interaction of
PhLP
with the cytosolic chaperonin complex appeared unnecessary.
PhLP
bound nascent Gbeta in the absence of Ggamma, and S18-20 phosphorylation was required for Ggamma to associate with the
PhLP
-Gbeta complex. Once Ggamma bound,
PhLP
was released. These results suggest a mechanism for Gbetagamma assembly in which
PhLP
stabilizes the nascent Gbeta polypeptide until Ggamma can associate, resulting in membrane binding of Gbetagamma and release of
PhLP
to catalyze another round of assembly.
...
PMID:Phosducin-like protein acts as a molecular chaperone for G protein betagamma dimer assembly. 1588 44
Phosducin-like protein
(
PhLP
) is a widely expressed binding partner of the G protein betagamma subunit complex (Gbetagamma) that has been recently shown to catalyze the formation of the Gbetagamma dimer from its nascent polypeptides. Phosphorylation of
PhLP
at one or more of three consecutive serines (Ser-18, Ser-19, and Ser-20) is necessary for Gbetagamma dimer formation and is believed to be mediated by the
protein kinase CK2
. Moreover, several lines of evidence suggest that the cytosolic chaperonin complex (CCT) may work in concert with
PhLP
in the Gbetagamma-assembly process. The results reported here delineate a mechanism for Gbetagamma assembly in which a stable ternary complex is formed between
PhLP
, the nascent Gbeta subunit, and CCT that does not include Ggamma.
PhLP
phosphorylation permits the release of a
PhLP
x Gbeta intermediate from CCT, allowing Ggamma to associate with Gbeta in this intermediate complex. Subsequent interaction of Gbetagamma with membranes releases
PhLP
for another round of assembly.
...
PMID:Mechanism of assembly of G protein betagamma subunits by protein kinase CK2-phosphorylated phosducin-like protein and the cytosolic chaperonin complex. 1671 95